Global Aldult CAR T-cell Therapy Supply, Demand and Key Producers, 2024-2030

Page: 91

Published Date: 29 Jul 2024

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Aldult CAR T-cell Therapy market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Aldult CAR T-cell Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Aldult CAR T-cell Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Aldult CAR T-cell Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Aldult CAR T-cell Therapy total market, 2019-2030, (USD Million)
Global Aldult CAR T-cell Therapy total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Aldult CAR T-cell Therapy total market, key domestic companies, and share, (USD Million)
Global Aldult CAR T-cell Therapy revenue by player, revenue and market share 2019-2024, (USD Million)
Global Aldult CAR T-cell Therapy total market by Type, CAGR, 2019-2030, (USD Million)
Global Aldult CAR T-cell Therapy total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Aldult CAR T-cell Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol Myers Squibb，BMS, Johnson & Johnson, Gilead Sciences, Novartis, JW Therapeutics, Imunopharm Technology Co., Ltd., CARsgen Therapeutics, Cartesian Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Aldult CAR T-cell Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Aldult CAR T-cell Therapy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Aldult CAR T-cell Therapy Market, Segmentation by Type
CD19
BCMA
Others

Global Aldult CAR T-cell Therapy Market, Segmentation by Application:
Multiple Myeloma
B-Cell Lymphoma (BCL)
Acute Lymphoblastic Leukemia (ALL)
Others

Companies Profiled:
Bristol Myers Squibb，BMS
Johnson & Johnson
Gilead Sciences
Novartis
JW Therapeutics
Imunopharm Technology Co., Ltd.
CARsgen Therapeutics
Cartesian Therapeutics

Key Questions Answered
1. How big is the global Aldult CAR T-cell Therapy market?
2. What is the demand of the global Aldult CAR T-cell Therapy market?
3. What is the year over year growth of the global Aldult CAR T-cell Therapy market?
4. What is the total value of the global Aldult CAR T-cell Therapy market?
5. Who are the Major Players in the global Aldult CAR T-cell Therapy market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Aldult CAR T-cell Therapy Introduction
    1.2 World Aldult CAR T-cell Therapy Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Aldult CAR T-cell Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World Aldult CAR T-cell Therapy Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Aldult CAR T-cell Therapy Revenue (2019-2030)
        1.3.3 China Based Company Aldult CAR T-cell Therapy Revenue (2019-2030)
        1.3.4 Europe Based Company Aldult CAR T-cell Therapy Revenue (2019-2030)
        1.3.5 Japan Based Company Aldult CAR T-cell Therapy Revenue (2019-2030)
        1.3.6 South Korea Based Company Aldult CAR T-cell Therapy Revenue (2019-2030)
        1.3.7 ASEAN Based Company Aldult CAR T-cell Therapy Revenue (2019-2030)
        1.3.8 India Based Company Aldult CAR T-cell Therapy Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Aldult CAR T-cell Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Aldult CAR T-cell Therapy Consumption Value (2019-2030)
    2.2 World Aldult CAR T-cell Therapy Consumption Value by Region
        2.2.1 World Aldult CAR T-cell Therapy Consumption Value by Region (2019-2024)
        2.2.2 World Aldult CAR T-cell Therapy Consumption Value Forecast by Region (2025-2030)
    2.3 United States Aldult CAR T-cell Therapy Consumption Value (2019-2030)
    2.4 China Aldult CAR T-cell Therapy Consumption Value (2019-2030)
    2.5 Europe Aldult CAR T-cell Therapy Consumption Value (2019-2030)
    2.6 Japan Aldult CAR T-cell Therapy Consumption Value (2019-2030)
    2.7 South Korea Aldult CAR T-cell Therapy Consumption Value (2019-2030)
    2.8 ASEAN Aldult CAR T-cell Therapy Consumption Value (2019-2030)
    2.9 India Aldult CAR T-cell Therapy Consumption Value (2019-2030)

3 World Aldult CAR T-cell Therapy Companies Competitive Analysis
    3.1 World Aldult CAR T-cell Therapy Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Aldult CAR T-cell Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Aldult CAR T-cell Therapy in 2023
        3.2.3 Global Concentration Ratios (CR8) for Aldult CAR T-cell Therapy in 2023
    3.3 Aldult CAR T-cell Therapy Company Evaluation Quadrant
    3.4 Aldult CAR T-cell Therapy Market: Overall Company Footprint Analysis
        3.4.1 Aldult CAR T-cell Therapy Market: Region Footprint
        3.4.2 Aldult CAR T-cell Therapy Market: Company Product Type Footprint
        3.4.3 Aldult CAR T-cell Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Aldult CAR T-cell Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Aldult CAR T-cell Therapy Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Aldult CAR T-cell Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Aldult CAR T-cell Therapy Consumption Value Comparison
        4.2.1 United States VS China: Aldult CAR T-cell Therapy Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Aldult CAR T-cell Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Aldult CAR T-cell Therapy Companies and Market Share, 2019-2024
        4.3.1 United States Based Aldult CAR T-cell Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Aldult CAR T-cell Therapy Revenue, (2019-2024)
    4.4 China Based Companies Aldult CAR T-cell Therapy Revenue and Market Share, 2019-2024
        4.4.1 China Based Aldult CAR T-cell Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Aldult CAR T-cell Therapy Revenue, (2019-2024)
    4.5 Rest of World Based Aldult CAR T-cell Therapy Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Aldult CAR T-cell Therapy Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Aldult CAR T-cell Therapy Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Aldult CAR T-cell Therapy Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 CD19
        5.2.2 BCMA
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World Aldult CAR T-cell Therapy Market Size by Type (2019-2024)
        5.3.2 World Aldult CAR T-cell Therapy Market Size by Type (2025-2030)
        5.3.3 World Aldult CAR T-cell Therapy Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World Aldult CAR T-cell Therapy Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Multiple Myeloma
        6.2.2 B-Cell Lymphoma (BCL)
        6.2.3 Acute Lymphoblastic Leukemia (ALL)
        6.2.4 Others
    6.3 Market Segment by Application
        6.3.1 World Aldult CAR T-cell Therapy Market Size by Application (2019-2024)
        6.3.2 World Aldult CAR T-cell Therapy Market Size by Application (2025-2030)
        6.3.3 World Aldult CAR T-cell Therapy Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 Bristol Myers Squibb，BMS
        7.1.1 Bristol Myers Squibb，BMS Details
        7.1.2 Bristol Myers Squibb，BMS Major Business
        7.1.3 Bristol Myers Squibb，BMS Aldult CAR T-cell Therapy Product and Services
        7.1.4 Bristol Myers Squibb，BMS Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Bristol Myers Squibb，BMS Recent Developments/Updates
        7.1.6 Bristol Myers Squibb，BMS Competitive Strengths & Weaknesses
    7.2 Johnson & Johnson
        7.2.1 Johnson & Johnson Details
        7.2.2 Johnson & Johnson Major Business
        7.2.3 Johnson & Johnson Aldult CAR T-cell Therapy Product and Services
        7.2.4 Johnson & Johnson Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Johnson & Johnson Recent Developments/Updates
        7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.3 Gilead Sciences
        7.3.1 Gilead Sciences Details
        7.3.2 Gilead Sciences Major Business
        7.3.3 Gilead Sciences Aldult CAR T-cell Therapy Product and Services
        7.3.4 Gilead Sciences Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Gilead Sciences Recent Developments/Updates
        7.3.6 Gilead Sciences Competitive Strengths & Weaknesses
    7.4 Novartis
        7.4.1 Novartis Details
        7.4.2 Novartis Major Business
        7.4.3 Novartis Aldult CAR T-cell Therapy Product and Services
        7.4.4 Novartis Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Novartis Recent Developments/Updates
        7.4.6 Novartis Competitive Strengths & Weaknesses
    7.5 JW Therapeutics
        7.5.1 JW Therapeutics Details
        7.5.2 JW Therapeutics Major Business
        7.5.3 JW Therapeutics Aldult CAR T-cell Therapy Product and Services
        7.5.4 JW Therapeutics Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 JW Therapeutics Recent Developments/Updates
        7.5.6 JW Therapeutics Competitive Strengths & Weaknesses
    7.6 Imunopharm Technology Co., Ltd.
        7.6.1 Imunopharm Technology Co., Ltd. Details
        7.6.2 Imunopharm Technology Co., Ltd. Major Business
        7.6.3 Imunopharm Technology Co., Ltd. Aldult CAR T-cell Therapy Product and Services
        7.6.4 Imunopharm Technology Co., Ltd. Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Imunopharm Technology Co., Ltd. Recent Developments/Updates
        7.6.6 Imunopharm Technology Co., Ltd. Competitive Strengths & Weaknesses
    7.7 CARsgen Therapeutics
        7.7.1 CARsgen Therapeutics Details
        7.7.2 CARsgen Therapeutics Major Business
        7.7.3 CARsgen Therapeutics Aldult CAR T-cell Therapy Product and Services
        7.7.4 CARsgen Therapeutics Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 CARsgen Therapeutics Recent Developments/Updates
        7.7.6 CARsgen Therapeutics Competitive Strengths & Weaknesses
    7.8 Cartesian Therapeutics
        7.8.1 Cartesian Therapeutics Details
        7.8.2 Cartesian Therapeutics Major Business
        7.8.3 Cartesian Therapeutics Aldult CAR T-cell Therapy Product and Services
        7.8.4 Cartesian Therapeutics Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Cartesian Therapeutics Recent Developments/Updates
        7.8.6 Cartesian Therapeutics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Aldult CAR T-cell Therapy Industry Chain
    8.2 Aldult CAR T-cell Therapy Upstream Analysis
    8.3 Aldult CAR T-cell Therapy Midstream Analysis
    8.4 Aldult CAR T-cell Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Aldult CAR T-cell Therapy Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Aldult CAR T-cell Therapy Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Aldult CAR T-cell Therapy Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Aldult CAR T-cell Therapy Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Aldult CAR T-cell Therapy Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Aldult CAR T-cell Therapy Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Aldult CAR T-cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Aldult CAR T-cell Therapy Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Aldult CAR T-cell Therapy Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Aldult CAR T-cell Therapy Players in 2023
 Table 12. World Aldult CAR T-cell Therapy Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Aldult CAR T-cell Therapy Company Evaluation Quadrant
 Table 14. Head Office of Key Aldult CAR T-cell Therapy Players
 Table 15. Aldult CAR T-cell Therapy Market: Company Product Type Footprint
 Table 16. Aldult CAR T-cell Therapy Market: Company Product Application Footprint
 Table 17. Aldult CAR T-cell Therapy Mergers & Acquisitions Activity
 Table 18. United States VS China Aldult CAR T-cell Therapy Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Aldult CAR T-cell Therapy Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Aldult CAR T-cell Therapy Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Aldult CAR T-cell Therapy Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Aldult CAR T-cell Therapy Revenue Market Share (2019-2024)
 Table 23. China Based Aldult CAR T-cell Therapy Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Aldult CAR T-cell Therapy Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Aldult CAR T-cell Therapy Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Aldult CAR T-cell Therapy Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Aldult CAR T-cell Therapy Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Aldult CAR T-cell Therapy Revenue Market Share (2019-2024)
 Table 29. World Aldult CAR T-cell Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Aldult CAR T-cell Therapy Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Aldult CAR T-cell Therapy Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Aldult CAR T-cell Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World Aldult CAR T-cell Therapy Market Size by Application (2019-2024) & (USD Million)
 Table 34. World Aldult CAR T-cell Therapy Market Size by Application (2025-2030) & (USD Million)
 Table 35. Bristol Myers Squibb，BMS Basic Information, Manufacturing Base and Competitors
 Table 36. Bristol Myers Squibb，BMS Major Business
 Table 37. Bristol Myers Squibb，BMS Aldult CAR T-cell Therapy Product and Services
 Table 38. Bristol Myers Squibb，BMS Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Bristol Myers Squibb，BMS Recent Developments/Updates
 Table 40. Bristol Myers Squibb，BMS Competitive Strengths & Weaknesses
 Table 41. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
 Table 42. Johnson & Johnson Major Business
 Table 43. Johnson & Johnson Aldult CAR T-cell Therapy Product and Services
 Table 44. Johnson & Johnson Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. Johnson & Johnson Recent Developments/Updates
 Table 46. Johnson & Johnson Competitive Strengths & Weaknesses
 Table 47. Gilead Sciences Basic Information, Manufacturing Base and Competitors
 Table 48. Gilead Sciences Major Business
 Table 49. Gilead Sciences Aldult CAR T-cell Therapy Product and Services
 Table 50. Gilead Sciences Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. Gilead Sciences Recent Developments/Updates
 Table 52. Gilead Sciences Competitive Strengths & Weaknesses
 Table 53. Novartis Basic Information, Manufacturing Base and Competitors
 Table 54. Novartis Major Business
 Table 55. Novartis Aldult CAR T-cell Therapy Product and Services
 Table 56. Novartis Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. Novartis Recent Developments/Updates
 Table 58. Novartis Competitive Strengths & Weaknesses
 Table 59. JW Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 60. JW Therapeutics Major Business
 Table 61. JW Therapeutics Aldult CAR T-cell Therapy Product and Services
 Table 62. JW Therapeutics Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. JW Therapeutics Recent Developments/Updates
 Table 64. JW Therapeutics Competitive Strengths & Weaknesses
 Table 65. Imunopharm Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
 Table 66. Imunopharm Technology Co., Ltd. Major Business
 Table 67. Imunopharm Technology Co., Ltd. Aldult CAR T-cell Therapy Product and Services
 Table 68. Imunopharm Technology Co., Ltd. Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. Imunopharm Technology Co., Ltd. Recent Developments/Updates
 Table 70. Imunopharm Technology Co., Ltd. Competitive Strengths & Weaknesses
 Table 71. CARsgen Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 72. CARsgen Therapeutics Major Business
 Table 73. CARsgen Therapeutics Aldult CAR T-cell Therapy Product and Services
 Table 74. CARsgen Therapeutics Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. CARsgen Therapeutics Recent Developments/Updates
 Table 76. CARsgen Therapeutics Competitive Strengths & Weaknesses
 Table 77. Cartesian Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 78. Cartesian Therapeutics Major Business
 Table 79. Cartesian Therapeutics Aldult CAR T-cell Therapy Product and Services
 Table 80. Cartesian Therapeutics Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Cartesian Therapeutics Recent Developments/Updates
 Table 82. Cartesian Therapeutics Competitive Strengths & Weaknesses
 Table 83. Global Key Players of Aldult CAR T-cell Therapy Upstream (Raw Materials)
 Table 84. Global Aldult CAR T-cell Therapy Typical Customers


List of Figures
 Figure 1. Aldult CAR T-cell Therapy Picture
 Figure 2. World Aldult CAR T-cell Therapy Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Aldult CAR T-cell Therapy Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Aldult CAR T-cell Therapy Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Aldult CAR T-cell Therapy Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Aldult CAR T-cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Aldult CAR T-cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Aldult CAR T-cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Aldult CAR T-cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Aldult CAR T-cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Aldult CAR T-cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Aldult CAR T-cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 13. Aldult CAR T-cell Therapy Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Aldult CAR T-cell Therapy Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Aldult CAR T-cell Therapy by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Aldult CAR T-cell Therapy Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Aldult CAR T-cell Therapy Markets in 2023
 Figure 27. United States VS China: Aldult CAR T-cell Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Aldult CAR T-cell Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Aldult CAR T-cell Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Aldult CAR T-cell Therapy Market Size Market Share by Type in 2023
 Figure 31. CD19
 Figure 32. BCMA
 Figure 33. Others
 Figure 34. World Aldult CAR T-cell Therapy Market Size Market Share by Type (2019-2030)
 Figure 35. World Aldult CAR T-cell Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 36. World Aldult CAR T-cell Therapy Market Size Market Share by Application in 2023
 Figure 37. Multiple Myeloma
 Figure 38. B-Cell Lymphoma (BCL)
 Figure 39. Acute Lymphoblastic Leukemia (ALL)
 Figure 40. Others
 Figure 41. World Aldult CAR T-cell Therapy Market Size Market Share by Application (2019-2030)
 Figure 42. Aldult CAR T-cell Therapy Industrial Chain
 Figure 43. Methodology
 Figure 44. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Bristol Myers Squibb，BMS
Johnson & Johnson
Gilead Sciences
Novartis
JW Therapeutics
Imunopharm Technology Co., Ltd.
CARsgen Therapeutics
Cartesian Therapeutics

Related Reports

Global Aldult CAR T-cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Aldult CAR T-cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 29 Jul 2024

date Service & Software

According to our (Global Info Research) latest study, the global Aldult CAR T-cell Therapy market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

Product Tags

Aldult CAR T-cell Therapy

soil fertility

Image High Dynamic

Building Energy Modeling

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>